Bone Health Awareness Sale ends in 00days 00hrs 00min
← Learn

Skin Changes After 45: What the Collagen Research Actually Shows

July 20, 2026 · Optimum Research Team

Quick answer: After 45, skin loses collagen faster than it can replace it. 2 things happen at once. Fibroblasts slow their collagen production as estrogen falls, and the enzymes that break collagen down keep running at their usual pace. Hydrolyzed collagen peptides address the first part by signaling fibroblasts to produce more. Antioxidants address the second part by slowing the oxidative damage that degrades collagen and makes it stiff. Here is what the evidence shows for both.

What changes in skin after 45 and why

The visible surface of skin is supported by a dense protein matrix in the layer below it called the dermis. That matrix is built mostly from collagen, organized into fibers that give skin its thickness, structure, and the rebound that allows it to spring back after movement.

Collagen is not static. It is being broken down and rebuilt continuously by cells called fibroblasts. What changes after 45 is the ratio between those 2 processes. Fibroblast activity is regulated significantly by estrogen. When estrogen falls at menopause, fibroblasts slow their output. The enzymes that break collagen down, called matrix metalloproteinases, do not slow at the same rate. Net loss follows.

A second mechanism compounds the first. Oxidative stress, the internal damage from free radicals, rises as estrogen's antioxidant protection fades. Free radicals attack collagen fibers directly and create abnormal chemical bonds between them, a process called cross-linking. Those cross-links make skin stiff and inflexible rather than supple, contributing to the texture changes many women notice in their 50s that go beyond simple thinning.

These 2 mechanisms, lower synthesis combined with higher breakdown and cross-linking, are why skin care after menopause involves meaningfully different targets than before.

Type I and type III collagen: what each one does

Not all collagen in skin serves the same function.

Type I is the dominant structural protein. It makes up roughly 80 percent of the collagen in the dermis and provides tensile strength and thickness. When type I depletes, skin becomes thinner and more fragile. That thinning is measurable on ultrasound imaging within a few years of menopause.

Type III fills the spaces between type I fibers. It is more flexible and is associated with skin elasticity and wound healing. It also appears in higher proportions in younger skin and declines as the type I framework degrades.

After 45, both decline. Type I tends to fall faster in the early post-menopausal years when the estrogen drop is steepest. The ratio between them shifts, which is why skin after menopause often becomes both thinner and less elastic simultaneously, rather than just one or the other.

How hydrolyzed collagen peptides work

Whole collagen protein cannot be absorbed meaningfully through the gut in its intact form. The molecule is too large. Hydrolyzation breaks collagen into short-chain peptides, typically di- and tripeptides, that the small intestine can absorb directly into the bloodstream.

Once absorbed, these peptides reach the dermis through circulation. Their mechanism there is often misunderstood. The body does not use them directly as building material. They act as signals. Fibroblasts recognize short collagen fragments as signs of local collagen breakdown and respond by upregulating collagen production. The signal communicates, in effect, that collagen is being lost and more needs to be made.

This is why the meaningful outcome in collagen research is not the amount of peptides in the blood after supplementation. It is the markers that show how much new collagen the body is actively synthesizing.

The Neltner study and what the human evidence shows

A randomized, double-blind, placebo-controlled trial tested hydrolyzed collagen peptides at 500 mg and 1000 mg per day over 8 weeks in 35 participants. The outcome was Pro-C1alpha1, a validated serum marker of active type-1 collagen synthesis.

At 500 mg per day, the synthesis marker rose 94 percent compared to placebo. At 1000 mg per day, it rose 165 percent, with absolute levels climbing from 42.7 to 113.1 nanograms per milliliter. The breakdown marker hydroxyproline fell 29 percent in the 500 mg group. Both synthesis rising and breakdown falling together is the combination that produces net collagen gain.

1 honest caveat: the trial enrolled men. The collagen synthesis signaling mechanism is not fundamentally sex-specific, but a trial in postmenopausal women with this level of rigor has not been published. That gap is worth naming rather than papering over. What the trial establishes is that the mechanism operates in real human physiology at achievable doses over a realistic timeframe.

Visible skin changes from collagen supplementation have been measured in other trials, mostly European and smaller, over 8 to 24 weeks, with consistent improvements in elasticity and hydration scores. The blood-marker change the Neltner trial measured is upstream of those visible changes.

Where antioxidants fit in the skin picture

Collagen supplementation supports production. Antioxidants support protection against degradation. The 2 mechanisms of collagen loss work simultaneously, and addressing only 1 is addressing half the problem.

Vitamin C is the clearest example. It is not optional in collagen synthesis chemistry. Vitamin C is a required cofactor for the enzymes that hydroxylate proline and lysine residues during collagen fiber formation. Without adequate vitamin C, collagen synthesis slows regardless of how strongly fibroblasts are signaled to produce. The peptide signal and the vitamin C cofactor work together.

Polyphenols and other dietary antioxidants scavenge the free radicals that drive cross-linking. The evidence here is more mechanistic and observational than from large intervention trials, so the role is protective rather than restorative. Antioxidants slow the damage that collagen is already sustaining; they do not undo what has already cross-linked.

Sun exposure compounds the picture after menopause. UV radiation independently degrades collagen and generates free radicals that accelerate cross-linking. When the body's natural antioxidant defenses have already weakened alongside estrogen, sun damage hits harder than it did before. This is why sun protection is not separate from the collagen question; it is part of it.

What holds up and what is overstated

The evidence supports several things plainly.

Collagen loss after menopause is documented and the mechanism is understood. Hydrolyzed collagen peptides have a real and studied signaling mechanism. The Neltner trial showed that mechanism produces meaningful changes in collagen synthesis markers over 8 weeks at achievable doses. Vitamin C is genuinely required for collagen synthesis to proceed correctly. Antioxidants slow oxidative collagen degradation.

Several things are commonly overstated in the supplement market.

Visible skin transformation timelines are often compressed. Blood-marker changes appear in weeks. Visible changes in skin elasticity, hydration, and thickness in the trials that measure them take 12 to 24 weeks of consistent intake. Claims of visible change in 2 weeks do not match the biology.

The language of "rebuilding collagen" in marketing overstates what is happening. More accurately, collagen peptides support the system that builds collagen, by sending the signal fibroblasts respond to. That is a real and significant effect, but the distinction matters for setting realistic expectations.

Starting point also matters. The magnitude of visible improvement varies significantly depending on how much collagen loss has already occurred, cumulative sun exposure history, and genetics. 2 women of the same age can respond very differently to the same consistent protocol.

Safety and what to look for in a collagen product

Hydrolyzed collagen peptides from grass-fed sources are among the best-tolerated supplements in clinical research. Adverse events across trials have been minimal and comparable to placebo.

2 things matter in a collagen product beyond dose. Source matters because grass-fed bovine collagen avoids the pesticide and antibiotic residues that concentrate in conventionally raised animals. Testing matters because a certificate of analysis from a third-party lab verifies that the peptide profile and heavy metal limits match what is on the label. These are not marketing details. They are the difference between a product that delivers what the research supports and one that does not.

What this means for you

The research gives a real mechanism, not a promise. Fibroblasts do respond to collagen peptide signals. The Neltner trial showed synthesis markers moved substantially over 8 weeks. Vitamin C genuinely supports that process. Antioxidants slow the degradation that works against it.

The honest picture is one of ongoing support for a system that menopause has slowed down. Not a reversal of decades in a month, but a real, studied intervention working on the biology that is actually driving the change.

If you are looking for grass-fed hydrolyzed collagen peptides from a tested source, you can find Optimum Collagen here: https://www.liveoptimum.co/products/grass-fed-hydrolyzed-collagen-peptides

Frequently asked questions

How does menopause affect skin collagen?

Estrogen regulates the fibroblasts that produce collagen. When estrogen falls at menopause, fibroblast production slows while the enzymes that break collagen down continue at the same rate. The result is net collagen loss that accelerates in the first years after the last period, then continues more slowly.

Do collagen peptide supplements actually increase collagen in skin?

The mechanism is real. Hydrolyzed peptides signal fibroblasts to produce more collagen, and the Neltner trial found type-1 collagen synthesis markers rose 94 to 165 percent over 8 weeks. The trial enrolled men, which is an honest gap. The underlying signaling mechanism applies regardless of sex.

What is the difference between type I and type III collagen?

Type I makes up roughly 80 percent of dermal collagen and provides thickness and tensile strength. Type III provides elasticity and healing support. Both decline after 45.

How long does it take collagen supplements to affect skin?

Blood-marker changes appear within weeks. Visible changes in skin elasticity, thickness, and hydration in clinical trials typically take 12 to 24 weeks of consistent intake.

Where do antioxidants fit in skin aging?

Oxidative stress degrades collagen directly and causes cross-linking that makes skin stiff rather than supple. Vitamin C is a required cofactor for collagen-synthesizing enzymes. Antioxidants play a protective role, slowing degradation rather than reversing it.

References

  1. Neltner TJ, et al. Efficacy of orally administered collagen hydrolysate product: a randomized, double-blind, placebo-controlled study. J Dietary Suppl. 2023. https://pubmed.ncbi.nlm.nih.gov/36546868/
  2. Das A, et al. Shilajit supplementation in healthy women: skin perfusion and extracellular matrix gene expression. 2019. https://pubmed.ncbi.nlm.nih.gov/31161927/
  3. Schepetkin IA, et al. Fulvic acid and type II collagen secretion in chondrocytes. Cell Tissue Res. 1999. https://pubmed.ncbi.nlm.nih.gov/10398891/